GLICLAZIDA 30 MG COM LIB PROL CT BL AL AL X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1235202690033 -
GGREM
529920080067507 -
Código de barras
7897076922397
O que a fonte publica
- Detentor do registro
- RANBAXY FARMACÊUTICA LTDA
- Princípios ativos
- GLICLAZIDA
- Embalagem
- 30 MG COM LIB PROL CT BL AL AL X 60
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Genérico
- Classe terapêutica
- A10H - ANTIDIABÉTICOS SULFONILOURÉIAS PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "GLICLAZIDA 30 MG COM LIB PROL CT BL AL AL X 60",
"holder": "RANBAXY FARMACÊUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7897076922397"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "529920080067507",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "73.663.650/0001-90",
"priceRegime": "Regulado",
"productName": "GLICLAZIDA",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "30 MG COM LIB PROL CT BL AL AL X 60",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "39.15",
"icms-12": "44.49",
"icms-17": "47.17",
"icms-18": "47.74",
"icms-19": "48.33",
"icms-20": "48.94",
"icms-21": "49.56",
"icms-22": "50.19",
"icms-23": "50.84",
"icms-17.5": "47.45",
"icms-19.5": "48.63",
"icms-20.5": "49.25",
"icms-22.5": "50.52",
"icms-12-alc": "43.95",
"icms-17-alc": "46.60",
"icms-18-alc": "47.17",
"icms-19-alc": "47.75",
"icms-20-alc": "48.35",
"icms-21-alc": "48.96",
"icms-22-alc": "49.59",
"icms-23-alc": "50.23",
"withoutTaxes": "38.68",
"icms-17.5-alc": "46.89",
"icms-19.5-alc": "48.05",
"icms-20.5-alc": "48.65",
"icms-22.5-alc": "49.91"
},
"pisCofinsList": "Positiva",
"substanceText": "GLICLAZIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "53.96",
"icms-12": "61.32",
"icms-17": "65.02",
"icms-18": "65.80",
"icms-19": "66.62",
"icms-20": "67.46",
"icms-21": "68.31",
"icms-22": "69.18",
"icms-23": "70.08",
"icms-17.5": "65.40",
"icms-19.5": "67.03",
"icms-20.5": "67.89",
"icms-22.5": "69.64",
"icms-12-alc": "60.76",
"icms-17-alc": "64.42",
"icms-18-alc": "65.21",
"icms-19-alc": "66.01",
"icms-20-alc": "66.84",
"icms-21-alc": "67.68",
"icms-22-alc": "68.56",
"icms-23-alc": "69.44",
"withoutTaxes": "53.47",
"icms-17.5-alc": "64.82",
"icms-19.5-alc": "66.43",
"icms-20.5-alc": "67.26",
"icms-22.5-alc": "69.00"
},
"invalidBarcodes": [],
"activeSubstances": [
"GLICLAZIDA"
],
"therapeuticClass": "A10H - ANTIDIABÉTICOS SULFONILOURÉIAS PUROS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1235202690033",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10H",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:529920080067507"